Salmela P I, Juustila H, Kinnunen O, Koistinen P
Ann Clin Res. 1986;18(2):88-92.
A randomised, double-blind study comparing 25 mg of hydrochlorothiazide plus 2.5 mg of amiloride with 25 mg of hydrochlorothiazide alone was conducted in 40 elderly patients with mild to moderate hypertension. After 8 weeks of treatment, the target blood pressure, supine diastolic blood pressure less than 90 mm Hg, was obtained in 73% of the hydrochlorothiazide plus amiloride treated patients (n = 17) and in 41% of the hydrochlorothiazide treated patients (n = 19; p less than 0.05). However, there was no statistically significant difference in blood pressure reduction between the 2 groups. Four patients dropped out, 3 of them due to side-effects. Serum potassium and magnesium concentrations were reduced in the hydrochlorothiazide group and serum sodium concentration in the hydrochlorothiazide plus amiloride group. Our results suggest that in elderly hypertensive subjects, a higher proportion of patients could be managed with the low dose hydrochlorothiazide plus amiloride regimen than with the low dose hydrochlorothiazide regimen.
一项随机双盲研究在40例轻度至中度高血压老年患者中开展,比较了25毫克氢氯噻嗪加2.5毫克阿米洛利与单用25毫克氢氯噻嗪的疗效。治疗8周后,氢氯噻嗪加阿米洛利治疗组(n = 17)中73%的患者达到目标血压,即仰卧位舒张压低于90毫米汞柱,而氢氯噻嗪治疗组(n = 19)中这一比例为41%(p < 0.05)。然而,两组间血压降低幅度无统计学显著差异。4例患者退出研究,其中3例是由于副作用。氢氯噻嗪组血清钾和镁浓度降低,氢氯噻嗪加阿米洛利组血清钠浓度降低。我们的结果表明,在老年高血压患者中,与低剂量氢氯噻嗪方案相比,低剂量氢氯噻嗪加阿米洛利方案能使更高比例的患者得到有效治疗。